Department of Clinical Epidemiology and Biostatistics, McMaster University, Hamilton, ON, Canada.
Diabet Med. 2013 Jun;30(6):739-45. doi: 10.1111/dme.12087. Epub 2013 Feb 28.
To systematically review randomized trials that assessed the effects of computerized clinical decision support systems in ambulatory diabetes management compared with a non-computerized clinical decision support system control.
We included all diabetes trials from a comprehensive computerized clinical decision support system overview completed in January 2010, and searched EMBASE, MEDLINE, INSPEC/COMPENDEX and Evidence-Based Medicine Reviews (EBMR) from January 2010 to April 2012. Reference lists of related reviews, included articles and Clinicaltrials.gov were also searched. Randomized controlled trials of patients with diabetes in ambulatory care settings comparing a computerized clinical decision support system intervention with a non-computerized clinical decision support system control, measuring either a process of care or a patient outcome, were included. Screening of studies, data extraction, risk of bias and quality of evidence assessments were carried out independently by two reviewers, and discrepancies were resolved through consensus or third-party arbitration. Authors were contacted for any missing data.
Fifteen trials were included (13 from the previous review and two from the current search). Only one study was at low risk of bias, while the others were of moderate to high risk of bias because of methodological limitations. HbA1c (3 months' follow-up), quality of life and hospitalization (12 months' follow-up) were pooled and all favoured the computerized clinical decision support systems over the control, although none were statistically significant. Triglycerides and practitioner performance tended to favour computerized clinical decision support systems although results were too heterogeneous to pool.
Computerized clinical decision support systems in diabetes management may marginally improve clinical outcomes, but confidence in the evidence is low because of risk of bias, inconsistency and imprecision.
系统评价比较计算机临床决策支持系统与非计算机临床决策支持系统对照在门诊糖尿病管理中效果的随机试验。
我们纳入了 2010 年 1 月完成的一项计算机临床决策支持系统全面综述中的所有糖尿病试验,并检索了 EMBASE、MEDLINE、INSPEC/COMPENDEX 和循证医学评价(EBMR),检索时间截至 2012 年 4 月。还检索了相关综述的参考文献、纳入的文章和 Clinicaltrials.gov。纳入了在门诊环境中比较计算机临床决策支持系统干预与非计算机临床决策支持系统对照,测量护理过程或患者结局的糖尿病患者的随机对照试验。两名评审员独立进行研究筛选、数据提取、偏倚风险和证据质量评估,通过协商或第三方仲裁解决分歧。对于任何缺失数据,我们联系了作者。
纳入了 15 项试验(13 项来自之前的综述,2 项来自本次检索)。仅有 1 项研究的偏倚风险较低,而其余研究由于方法学局限性,其偏倚风险为中度至高度。糖化血红蛋白(3 个月随访)、生活质量和住院率(12 个月随访)被合并,所有结局均支持计算机临床决策支持系统优于对照组,尽管无统计学意义。甘油三酯和医生表现倾向于支持计算机临床决策支持系统,但结果过于异质而无法合并。
在糖尿病管理中,计算机临床决策支持系统可能略微改善临床结局,但由于存在偏倚风险、不一致性和不精确性,对证据的信心较低。